Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma (Q44677297)

5 December 2017

title

Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma (English)

1 reference

5 December 2017

1 reference

5 December 2017

S Darb-Esfahani

1 reference

5 December 2017

F Fritzsche

1 reference

5 December 2017

G Kristiansen

1 reference

5 December 2017

W Weichert

1 reference

5 December 2017

J Sehouli

1 reference

5 December 2017

I Braicu

1 reference

5 December 2017

M Dietel

1 reference

5 December 2017

publication date

3 July 2012

1 reference

5 December 2017

1 reference

5 December 2017

volume

461

1 reference

5 December 2017

1 reference

5 December 2017

page(s)

109-116

1 reference

The biology of ovarian cancer: new opportunities for translation

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

First-line therapy in ovarian cancer trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Progressive determination during formation of the anteroposterior axis in Xenopus laevis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Anterior gradient 2: A novel player in tumor cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Prognostic relevance of AGR2 expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Differential expression of anterior gradient gene AGR2 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Anterior gradient-2 is overexpressed by fibrolamellar carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

My approach to and thoughts on the typing of ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Evaluation of midkine and anterior gradient 2 in a multimarker panel for the detection of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Physiological stress induces the metastasis marker AGR2 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1273-4

Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22752467

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of AGR2 in non small cell lung cancer.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22752467

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22752467

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00428-012-1273-4

1 reference

5 December 2017

1 reference